Treace Reports Five-Year ALIGN3D Lapiplasty Outcomes
PONTE VEDRA, Fla. — September 17, 2026 Treace Medical Concepts announced clinical results from three studies evaluating its Lapiplasty®,...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
PONTE VEDRA, Fla. — September 17, 2026 Treace Medical Concepts announced clinical results from three studies evaluating its Lapiplasty®,...
Houston, Texas, August 20, 2026 FibroBiologics, Inc., a clinical-stage biotechnology company developing regenerative therapies based on fibroblast cells and...
HOUSTON, August 18, 2026 FibroBiologics, Inc., a clinical-stage biotechnology company developing therapies based on fibroblast cells and fibroblast-derived materials,...
LONDON, United Kingdom, July 29, 2026 Smith+Nephew has achieved a significant regulatory milestone after receiving U.S. Food and Drug...
Plantation, Florida, USA — July 24, 2026 Advita Ortho has announced the first clinical use of Equinoxe® Reverse Shoulder...
HERZLIYA, Israel, July 15, 2026 Regentis Biomaterials announced that it has received approval from the European Notified Body for...
DUBLIN, Ireland, July 8, 2026 Keenova Therapeutics plc has announced positive Phase 3 clinical trial results for XIAFLEX® (collagenase...
TOKOROZAWA, Japan, June 30, 2026 Advita Ortho announced the first clinical use of its next-generation knee replacement platform in...
BOCA RATON, Fla., June 2026 SurGenTec® has announced U.S. FDA clearance for its ION-L™ Lumbar Facet Fixation System, a...
COPENHAGEN, Denmark and NEW YORK, June 10, 2026 HERVolution Therapeutics has announced compelling preclinical proof-of-concept data demonstrating the potential...
